4.8 Article

Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling

Journal

SCIENCE
Volume 377, Issue 6614, Pages 1510-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.adc8969

Keywords

-

Funding

  1. National Health and Medical Research Council (NHMRC) [1196590, 1107804, 1160570, 1071659, 1108859]
  2. Australian Research Council (ARC) Future Fellowship [FT200100572]
  3. ARC Laureate Fellowship [FL180100109]
  4. ARC Discovery Early Career Researcher Award [DE170100783]
  5. National Institutes of Health [R01NS087632]
  6. Biotechnology and Biological Sciences Research Council [BB/V00400X/1]
  7. Griffith University Postdoctoral Fellowship Scheme
  8. Nebraska Soybean Board [1734]
  9. Australian Research Council [FT200100572] Funding Source: Australian Research Council

Ask authors/readers for more resources

This study reveals the production process of cADPR isomers and identifies 3'cADPR as an antiviral agent in bacteria and an immune-suppressing signaling molecule in plants.
Cyclic adenosine diphosphate (ADP)-ribose (cADPR) isomers are signaling molecules produced by bacterial and plant Toll/interleukin-1 receptor (TIR) domains via nicotinamide adenine dinucleotide (oxidized form) (NAD(+)) hydrolysis. We show that v-cADPR (2'cADPR) and v2-cADPR (3'cADPR) isomers are cyclized by O-glycosidic bond formation between the ribose moieties in ADPR. Structures of 2'cADPR-producing TIR domains reveal conformational changes that lead to an active assembly that resembles those of Toll-like receptor adaptor TIR domains. Mutagenesis reveals a conserved tryptophan that is essential for cyclization. We show that 3'cADPR is an activator of ThsA effector proteins from the bacterial antiphage defense system termed Thoeris and a suppressor of plant immunity when produced by the effector HopAM1. Collectively, our results reveal the molecular basis of cADPR isomer production and establish 3'cADPR in bacteria as an antiviral and plant immunity-suppressing signaling molecule.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available